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Second case of European bat lyssavirus 
type 2 detected in a Daubenton’s bat in Finland
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Abstract 
European bat lyssavirus type 2 (EBLV-2) was detected in Finland in a Daubenton’s bat (Myotis daubentonii) found in 
the municipality of Inkoo (60°02′45″N, 024°00′20″E). The bat showed neurological signs and was later found dead. 
The laboratory analysis revealed the presence of lyssavirus, and the virus was characterized as EBLV-2. This isolation of 
EBLV-2 was the second time that the virus has been detected in a Daubenton’s bat in Finland. This provides additional 
proof that EBLV-2 is endemic in the Finnish Daubenton’s bat population.
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Findings
Rabies is a fatal encephalomyelitis caused by lyssaviruses 
with a case fatality rate of almost 100%. Rabies virus 
(RABV) causes about 99% of all rabies cases in humans, 
mostly in Asia and Africa. Thirteen other lyssavirus spe-
cies have been accepted by the International Committee 
on Taxonomy of Viruses [1] and two additional species 
have been identified Lleida bat lyssavirus from Spain in 
2011 [2] and Gannoruwa Bat Lyssavirus from Sri Lanka 
in 2015 [3]. Bats are considered to be the true reservoir of 
lyssaviruses [4]. There is evidence that bats seroconvert 
after exposure to lyssaviruses without development of 
clinical signs, but in some cases, bats develop clinical dis-
ease similar to rabies in other mammals and death occurs 
after the appearance of clinical signs [5]. Finland has 
been free of RABV since 1991, but European bat lyssa-
virus type 2 (EBLV-2) was detected in 2009 in a Dauben-
ton’s bat (Myotis daubentonii) [6]. In addition, antibodies 
against lyssavirus have been detected in Daubenton’s bats 
from the same area [7]. EBLV-2 has sporadically been iso-
lated from bats in the Netherlands [8], Switzerland [9], 
the United Kingdom [10], Finland [6], Germany [11] and 
Norway [12]. EBLV-2 has caused two human cases: in 
Finland in 1985 [13] and in the United Kingdom in 2002 
[14]. Both victims were researchers studying bats and 
they did not receive pre- or post-exposure rabies prophy-
laxis. No spill-over infections to other mammals than 
humans have been detected for EBLV-2.
A private citizen observed an abnormally behaving 
bat at a summer cottage in the municipality of Inkoo 
(60°02′45″N, 024°00′20″E) in October, 2016. Inkoo is 
in the province of southern Finland and is part of the 
Uusimaa region. The bat exhibited behavioral changes: 
it appeared during daytime, was unable to crawl into 
the roof space of a building, and had difficulties in mov-
ing and flying. When crawling on the wall, the bat had 
severe ataxia and tetraparesis. Later that day, the bat was 
grounded and found dead. It was sent to the Finnish Food 
Safety Authority Evira for autopsy. The Daubenton’s bat 
was a cachexic adult female, weighing circa 7 g (Fig. 1).
The presence of lyssavirus was detected in the brain by 
fluorescent antibody test (FAT) [15]. Smears prepared 
from a sample of brain tissue were fixed in high-grade 
cold acetone, air dried, and then stained with specific 
conjugate (FITC Anti-Rabies Monoclonal Globulin, 
Fujirebio Diagnostics and Rabies Antinucleocapsid con-
jugate, Bio-Rad). FAT slides were examined for spe-
cific fluorescence using a fluorescence microscope with 
positive results. The brain suspension of the bat was 
inoculated in mouse neuroblast cells Neuro-2a  (ATCC® 
CCL-131™) according to a rabies tissue culture infectious 
test (RTCIT) procedure described in the OIE manual 
[15], and the virus isolation for lyssavirus was positive. 
Additional organ and swab samples were collected from 
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the bat. RNA was extracted from the organ and swab sus-
pensions of the bat with the QIAamp Viral RNA Mini Kit 
(Qiagen, Hilden, Germany) according to the manufactur-
er’s instructions. The OneStep RT-PCR kit (Qiagen) was 
used to amplify two fragments. The reaction volume was 
25 µL and the temperature profile of cDNA synthesis and 
amplification was 30  min at 50  °C, 15  min at 94  °C for 
reverse transcriptase inactivation and DNA polymerase 
activation, followed by 30 amplification cycles of 1 min at 
94 °C, 1 min at 50 °C, and 1 min at 72 °C. Primers were 
published by Davis et  al. [16]. The results are presented 
in Table  1. After agarose gel electrophoresis, the band 
of the brain sample was cut from the gel and DNA was 
extracted with the Qiaquick Gel Extraction Kit (Qiagen). 
The reaction products were purified using the DyeEx 2.0 
Spin Kit (Qiagen). PCR products were sequenced using 
an ABI 3100 Avant Genetic Analyzer (Applied Biosys-
tems) with the primers used in the PCR and a Big Dye 
Terminator v3.1 Cycle sequencing kit (Applied Biosys-
tems). The sequences were analyzed with DNASTAR 
Lasergene 10.
There have been two cases of EBLV-2 from Dauben-
ton’s bats in Finland, the first in 2009 [6] and now in 2016. 
This provides further evidence that EBLV-2 is enzootic in 
Daubenton’s bats in Finland, at least in the southwestern 
part of the country. However, we consider the risk of 
EBLV-2 infection of humans as extremely low. Adequate 
information should be given to the general public on 
what to do when they come into contact with bats. Peo-
ple who handle bats due to their work or hobby should 
be vaccinated against rabies according to the guidelines 
of WHO [17].
Even though Daubenton’s bats are most likely the true 
reservoir of EBLV-2, they can become diseased and show 
typical neurological signs of rabies: abnormal behavior, 
paralysis, and coma followed by death. Therefore, pas-
sive surveillance of sick and dead bats is the most impor-
tant surveillance method. Researchers studying bats and 
members of the public play a key role in providing sam-
ples to the diagnostics laboratory. Active surveillance of 
healthy bats has seldom revealed lyssaviruses from bats 
[7, 18].
FAT has been proved to be effective in detecting 
EBLV-2 from infected bats, but in one recorded case, the 
FAT test was negative on a bat sample even though viral 
RNA was detected by RT-PCR and the virus was isolated 
in a cell culture. Some laboratories have had difficulties 
to reliably detect EBLV strains when using the FAT, with 
results depending on the rabies virus antibody conjugate 
and even the batch used [12].
The viral RNA was detected by RT-PCR and the via-
ble virus was isolated using mouse neuroblast cells 
from the brain, the spinal cord and the salivary glands, 
but not from other organ or swab samples (Table  1). 
The virus was identified as EBLV-2 based on partial 
N-gene sequencing and phylogenetic analysis (Fig.  2). 
The sequence (GenBank Accession Number MF326269) 
was 98% identical to previously found EBLV-2 strains in 
Finland. The isolated EBLV-2 was also phylogenetically 
very similar to the strains characterized in other parts of 
Europe [19]. Characterization of the isolated lyssaviruses 
provides valuable information on the epidemiological sit-
uation of the reservoir of specific lyssavirus and possible 
spill-over species.
Fig. 1 The Daubenton’s bat found dead in the municipality of Inkoo, 
SW Finland. Courtesy of Riitta Räisänen
Table 1 Results of lyssavirus detection from different organ and swab samples from the Daubenton’s bat
FAT fluorescent antibody test, RTCIT rabies tissue culture infectious test, NA not applicable
Brain Spinal cord Salivary gland Mouth swab Anal swab Tongue Intestines Liver Eye Lung Trachea Bladder Tonsils
FAT + + NA NA NA NA NA NA NA NA NA NA NA
RTCIT + + + − − − − − − − − − −
RT-PCR + + + − − − − − − − − − −
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